A Double-blind Study of the Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog 174; in Subjects With Type 1 Diabetes Including Assessments of Safety and Injection Site Toleration.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2013
At a glance
- Drugs Insulin (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 04 Aug 2011 Status changed from recruiting to completed, as reported in a Biodel media release.
- 16 Apr 2011 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History